Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: Lessons learned from a microbicide phase III clinical trial

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Crucitti, Tania ^a   Fransen, Katrien ^a   Maharaj, Rashika ^b   Tenywa, Tom ^c   Loembé, Marguerite Massinga ^d,e   Murugavel, Kailapuri Gangatharan ^f   Mendonca, Kevin ^g   Abdellati, Said ^a   Beelaert, Greet ^a   van Damme, Lut ^h,i  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c MAKERERE UNIVERSITY   (Uganda)

^d UNIVERSITÉ LAVAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^g ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^h EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

ⁱ FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE SULFATE; PLACEBO; TOPICAL ANTIINFECTIVE AGENT;

AFRICA; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFORMATION RETRIEVAL; LABORATORY TEST; MEDICAL ERROR; MEDICAL INFORMATION; METHODOLOGY; MULTICENTER STUDY; NEISSERIA GONORRHOEAE; NONHUMAN; PHASE 3 CLINICAL TRIAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SEXUALLY TRANSMITTED DISEASE; VALIDITY; VIRUS IDENTIFICATION; DEVELOPING COUNTRY; VALIDATION STUDY;

CHLAMYDIA;

AFRICA; ANTI-INFECTIVE AGENTS, LOCAL; DEVELOPING COUNTRIES; HUMANS; INDIA; QUALITY CONTROL;

EID: 78149459926     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013592     Document Type: Article

References (10)

1. Van Damme L, Govinden R, Mirembe FM, Guedou F, Solomon S, et al. (2008) Lack of effectiveness of cellulose sulfate gel for prevention of vaginal HIV transmission. N Engl J Med 359: 463-72.
2. Crucitti T, Jespers V, Van Damme L, Van Dyck E, Buvé A (2007) Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection. Diagn Microbiol Infect Dis 57: 97-9.
3. World Health Organization (2004) Rapid HIV tests: guidelines for use in HIV testing and counselling services in resource-constrained settings. World Health Organization: Geneva.
4. Stiles T, Grant V, Mawby N (2005) Good Clinical Laboratory Practice: A quality system for laboratories that undertake the analyses of samples from clinical trials. Barqa: Suffolk.
5. Ezzelle J, Rodriguez-Chavez IR, Darden JM, Stirewalt M, Kunwar N, et al. (2008) Guidelines on good clinical laboratory practice: Bridging operations between research and clinical research laboratories. J Pharm Biomed Anal 46: 18-29.
6. Sarzotti-Kelsoe M, Cox J, Cleland N, Denny T, Hural J, et al. (2009) Evaluation and recommendation on Good Clinical Laboratory Practice guideline for phase I-III clinical trials. Plos Med 6(5): e1000067. doi:10.1371/journal. pmed.1000067.
7. Wertheim HF, Puthavathana P, Nghiem NM, van Doorn RH, Nguyen TV, et al. (2010) Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med 7(4): e1000231. doi: 10.1371/journal. pmed.1000231.
8. Bompart F, Hirsch F, Betroye P-H, Vray M, and The participants in Round Table No1, Giens XXIII (2008) Good Clinical Practice in developing countries: applying recommendations. Thérapie 63: 83-88.
9. Stevens W (2003) Good Clinical Laboratory Practice (GCLP): the need for a hybrid of good laboratory practice and good clinical practice guidelines/ standards for medical testing laboratories conducting clinical trials in developing countries. Qual Assur 10: 83-89.
10. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA (2006) Laboratory medicine in Africa: A barrier to effective health care. Clin Infect Dis 42: 377-382.